For the quarter ending 2026-03-31, FONR had $673,000 increase in cash & cash equivalents over the period. $1,409,000 in free cash flow.
| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Consolidated net income | 2,328,000 | 2,539,000 | 2,670,000 | 10,673,433 |
| Depreciation and amortization | 1,106,000 | 1,151,000 | 1,190,000 | - |
| Net change in operating right-of-use assets and lease liabilities | -117,000 | -128,000 | -125,000 | 493 |
| Depreciation and amortization | - | - | - | 4,698,321 |
| (recovery) provision for credit losses | -183,000 | - | - | - |
| Provision for credit losses | - | - | - | 3,206,756 |
| (recovery) provision for credit losses | - | -436,000 | 99,000 | - |
| Abandoned patents | 3,000 | - | - | 55,707 |
| Deferred tax expense | -42,000 | 161,000 | 35,000 | 823,660 |
| Gain on sale of equipment related party | - | - | - | 0 |
| Accounts, medical and management fee receivable | 3,037,000 | 771,000 | 1,544,000 | 9,005,766 |
| Gain on disposition of fixed assets | - | - | - | 0 |
| Notes receivable related party | -12,000 | -13,000 | -12,000 | -26,326 |
| Inventories | 78,000 | 5,000 | -64,000 | 97,241 |
| Prepaid expenses and other current assets | 270,000 | 22,000 | -340,000 | 1,194,922 |
| Other assets | 0 | 37,000 | 378,000 | -5,467 |
| Accounts payable | 376,000 | -609,000 | 1,218,000 | -553,562 |
| Other current liabilities | 936,000 | -2,106,000 | -2,078,000 | 2,655,567 |
| Customer advances | - | - | - | -89,227 |
| Finance lease liabilities | -61,000 | -61,000 | -41,000 | -79,970 |
| Customer deposits | 80,000 | 250,000 | -3,000 | - |
| Other liabilities | -20,000 | 2,000 | 4,000 | 140,826 |
| Net cash provided by operating activities | 1,580,000 | 171,000 | 1,689,000 | 11,264,882 |
| Purchases of property and equipment | 171,000 | 398,000 | 1,866,000 | 3,791,581 |
| Cost of non-compete contract | 0 | 0 | 500,000 | - |
| Proceeds from short-term investments | - | - | 1,000 | -15,608 |
| Proceeds from sale of equipment | - | - | - | 0 |
| (purchase) proceeds from short-term investments | 2,000 | - | - | - |
| Cost of patents | 0 | 1,000 | - | 25,325 |
| Net cash used in investing activities | -173,000 | -398,000 | -2,367,000 | -3,801,298 |
| Repayment of borrowings and finance obligations | - | - | - | 113,940 |
| Sale of noncontrolling interest | - | - | - | 132,000 |
| Purchase of treasury stock | - | - | - | 1,806,646 |
| Distributions to noncontrolling interests | 734,000 | 1,072,000 | 1,380,000 | 5,682,555 |
| Net cash used in financing activities | -734,000 | -1,072,000 | -1,380,000 | -7,471,141 |
| Net decrease in cash and cash equivalents | 673,000 | -1,299,000 | -2,058,000 | -7,557 |
| Cash and cash equivalents - beginning of period | 52,977,000 | 54,276,000 | 56,334,000 | 56,341,193 |
| Cash and cash equivalents - end of period | 53,650,000 | 52,977,000 | 54,276,000 | 56,333,636 |